02-15-2019 11:03 AM CET - Health & Medicine

Interventional Oncology Market - Growing Demand for Minimally Invasive Therapeutics Is the Major Driving Factor for the Market Growth

Press release from: Allied Market Research
Interventional Oncology Market
Interventional Oncology Market
Interventional oncology procedures include diagnosis and treatment of cancer with the help of minimally invasive procedures performed under image guidance. This procedure uses equipment such as X-ray, ultrasound, computed tomography or magnetic resonance imaging for induction purposes. The procedure is performed using guiding accessories and tools, including an incision electrode, a guide wire, a biopsy needle, and an intravascular catheter that enables the treatment of tumors located in remote parts of the body.

Interventional oncology is used to treat primary or metastatic cancers such as liver cancer, kidney cancer, lung cancer, bone cancer, prostate cancer, breast cancer and pancreatic cancer. Most of these procedures are performed in outpatients or need to stay overnight in the hospital. Minimal intrusiveness minimizes the required recovery time. Some of the popular procedures are pain relief, intra-arterial therapy, abstinence therapy and neoadjuvant procedures.

Download PDF Report Sample @ www.alliedmarketresearch.com/request-toc-and-sample/3702

Comprehensive competitive analysis and profiles of major market players such as
• Boston Scientific
• Accuray
• Medtronic
• AtriCure
• Baylis Medical
• Alpinion Medical Systems
• Terumo Corporation
• AngioDynamics
• Merit Medical

Demand for minimally invasive therapies is on the rise and is a major driver of market growth. This procedure can also be used to treat patients with other related complications and those who can not. The ability of minimally invasive techniques to better treat cancer cells than cancer therapies, such as radiation therapy, surgery and systemic chemotherapy, has helped popularize this technology.

In addition, medical professionals and patients are gradually adopting minimally invasive procedures in the field of interventional oncology due to the benefits of technology use such as shorter hospital stay, minimization of infection risk, minimization of complication risks, pain reduction and recovery time. This advantage of using at least invasive procedures will drive the growth of the global interventional oncology market.

Make an Enquiry before Buy @ www.alliedmarketresearch.com/purchase-enquiry/3702

The global interventional oncology market is segmented based on procedure and geography. Based on procedure, the market is categorized into radiation therapy, ablation, and particle embolization. Radiation therapy is further bifurcated into internal and external radiation therapy. Ablation is further categorized into cryoablation therapy, microwave ablation therapy, and radiofrequency ablation. Particle embolization is further classified into drug-eluting beads, radioembolization, microspheres, and polyvinyl alcohol particles. Based on geography, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits:
• This report provides an extensive analysis of the current and emerging market trends and dynamics in the global market.
• This report entails a detailed quantitative analysis of the current market and estimations from 2017-2023, which helps identify prevailing market opportunities.
• The projections in this report are made by analyzing the current trends and future market potential from 2017 to 2023 in terms of value.
• Competitive intelligence helps understand the competitive scenario globally
• An in-depth analysis of current research and clinical developments within the market has been provided with key market dynamic factors that help understand the behavior of the market

Access Full Summery @ www.alliedmarketresearch.com/interventional-oncology-market

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.


David Correa

5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States

Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975


This release was published on openPR.
News-ID: 1591738 • Views: 225
More releasesMore releases

You can edit or delete your press release here: